OKYO Pharma

Europe Legal Chronicle. June 1, 2022

OKYO Pharma’s U.S. Initial Public Offering

By Martina Bellini

Orrick advised OKYO Pharma on the deal. OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO), a biotechnology company focused on the discovery and development of novel molecules...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Pinnacle Group’s Investment in VSS Capital Partners

Parsec Education’s $8 Million Series A Funding Round

Impossible Foods Inc. v. Motif Foodworks, Inc.

Atlas Copco Brasil’s Acquisition of Metalplan Equipamentos

Kloeckner Metal Service Centers de México’s USD$115 Million Loan Agreement

AZ Quest Infra-Yield FIP-IE’s R$251 Million Shares Issuance

Genesis Energias S.A.’s Chartering Of BILBAO KNUTSEN LNG Floating Storage

Present Group’s Integration into Exprivia S.p.A.

Optimizely’s Debt Refinancing

National Egyptian Railway Industries Company’s EGP5 Billion Syndicated Loan

Harith InfraCo’s R6.5 Billion Acquisition of African Infrastructure Fund

Beltone’s Joint Venture Agreement with CRIF

Aldar’s Acquisition of a Commercial Office Tower in the Dubai International Financial Centre

TAV Airports’ €342 Million Long-Term Financing For Ankara Esenboga Airport

Vertex’s Acquisition of CBBG Group

Viva Energy’s Acquisition Of Remaining 50% Stake In Liberty Convenience

SAFCO Venture’s Project Financing For Sustainable Aviation Fuel Facility in Sheikhupura

Ørsted’s Equity Divestment and Financing Arrangements of Greater Changhua 4 Offshore Wind Project

O’Melveny To Add Seven New Partners in 2025

Veirano Advogados Starts 2025 with New Partners and Strengthened Practices

Sidley Adds Clive Gringras, Leading International Contentious, AI, and Transactional Tech Partner in London

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

O’Melveny To Add Seven New Partners in 2025

Veirano Advogados Starts 2025 with New Partners and Strengthened Practices

Sidley Adds Clive Gringras, Leading International Contentious, AI, and Transactional Tech Partner in London

OKYO Pharma’s U.S. Initial Public Offering

Standard 1 Year Membership Required